Form 4: Vertex Pharmaceuticals Inc / Ma Executive Receives Stock Gra
Insider Transaction (Form 4)
Ourania Tatsis, EVP, Chief Reg. & Quality Off. of Vertex Pharmaceuticals Inc / Ma, received 8,251 shares of common stock on July 21, 2026.
Summary
- Grant/award: acquired 8,251 Common Stock on July 21, 2026; holds 53,572 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ourania Tatsis — Officer (EVP, Chief Reg. & Quality Off.)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-21 | Grant/award | Common Stock | 8,251 | — | — | 53,572 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-21 | Grant/award (8,251 shares) |
Keywords
insider transaction, Form 4, VRTX, VERTEX PHARMACEUTICALS INC / MA, neutral, Ourania Tatsis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.